Vaccination against SARS-CoV-2 in a rural Ugandan population

Vaccination against SARS-CoV-2 in a rural Ugandan population

Working within the context of a longstanding cohort in rural southwestern Uganda (the General Population Cohort), we collect health-related data in successive survey rounds from all residents of 25 adjacent villages on a biannual basis. Between January 2022 and July 2022, 2318 adult participants in...

Full description

Bibliographic Details
Main Authors:	Joseph Mugisha, Bernard Mpairwe, Beatrice Kimono, Pontiano Kaleebu, Robert Newton
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Vaccine: X
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590136223000967

Similar Items

SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda
by: Joseph Mugisha, et al.
Published: (2023-01-01)

Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens
by: Hellen Nantambi, et al.
Published: (2023-04-01)

Thirty years of change in HIV incidence among adults in the Kyamulibwa General Population Cohort in rural southwest Uganda, 1989-2021
by: Ivan Kasamba, et al.
Published: (2023-04-01)

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population
by: Birgit Weinberger
Published: (2021-12-01)

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy
by: Jennifer Serwanga, et al.
Published: (2023-05-01)

HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfection
by: Andrew Ekii Obuku, et al.
Published: (2023-08-01)

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies
by: Violet Ankunda, et al.
Published: (2024-02-01)

Timely development of vaccines against SARS-CoV-2
by: Shan Lu
Published: (2020-01-01)

Nucleic Acid Vaccines against SARS-CoV-2
by: Ying Liu, et al.
Published: (2022-10-01)

Development of an Inactivated Vaccine against SARS CoV-2
by: Shaikh Terkis Islam Pavel, et al.
Published: (2021-11-01)

In Silico Design of a Multivalent Epitope Vaccine Against SARS-CoV-2 for Iranian Populations
by: Faezeh Soltanveis, et al.
Published: (2021-11-01)

Acquired immunity against SARS‐CoV‐2 infection and vaccination
by: Laurent Renia, et al.
Published: (2023-12-01)

Correlates of Vaccine-Induced Protection against SARS-CoV-2
by: Till Koch, et al.
Published: (2021-03-01)

Development of DNA Vaccine Candidate against SARS-CoV-2
by: Xingyun Wang, et al.
Published: (2022-05-01)

Progress and Prospects on Vaccine Development against SARS-CoV-2
by: Jinyong Zhang, et al.
Published: (2020-03-01)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021-10-01)

SARS CoV- 2 vaccination induces antibodies against cardiolipin
by: George Krashias, et al.
Published: (2022-09-01)

Design of Multi-Epitope Vaccine against SARS-CoV-2
by: Doytchinova Irini, et al.
Published: (2020-12-01)

Post-vaccination antibodies against SARS-CoV-2: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-12-01)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
by: Chiao-Hsuan Chao, et al.
Published: (2022-11-01)

SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022
by: Lauren E. Bloomfield, et al.
Published: (2023-06-01)

Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study
by: Annemarie Namuniina, et al.
Published: (2023-01-01)

Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study.
by: Annemarie Namuniina, et al.
Published: (2023-01-01)

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
by: Carmen Elena Gómez, et al.
Published: (2021-03-01)

An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2
by: Palmira Immordino, et al.
Published: (2023-11-01)

Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2
by: B. S. Cherepovich, et al.
Published: (2024-04-01)

Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2
by: Zsofia Hevesi, et al.
Published: (2022-03-01)

Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
by: Nikola Hudakova, et al.
Published: (2021-05-01)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
by: Miriam Echaide, et al.
Published: (2023-03-01)

Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
by: B. S. Belov, et al.
Published: (2022-03-01)

Designing a Novel Nano-Vaccine against SARS-CoV-2
by: Ang Gao, et al.
Published: (2020-12-01)

Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
by: Ousseny Zerbo, et al.
Published: (2023-02-01)

Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan
by: Cheng-Yi Lee, et al.
Published: (2024-03-01)

Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations
by: Elizabeth Titova, et al.
Published: (2024-03-01)

Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
by: Hansam Cho, et al.
Published: (2021-03-01)

Vaccination against SARS-COV‑2 in oncology
by: A. A. Polyakov, et al.
Published: (2021-06-01)

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2
by: Praveen Neeli, et al.
Published: (2023-07-01)

Chinese parents’ intentions to vaccinate their children against SARS-CoV-2 infection and vaccine preferences
by: Yulan Lin, et al.
Published: (2021-12-01)

Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2
by: Iman Almansour, et al.
Published: (2021-01-01)

Challenges and developments in universal vaccine design against SARS-CoV-2 variants
by: Fangxin Zhao, et al.
Published: (2022-12-01)